Innovation in a risk-averse industry with Adam Walker

Innovation in a risk-averse industry with Adam Walker

From Clinical Data Talks by CRScube

April 1, 2026 · 28 min · Season 3 · Episode 2

About this episode

Adam Walker discusses the balance between innovation and risk aversion in the clinical research industry.

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Adam Walker, a seasoned clinical data management and biometrics consultant. Together, they explore the delicate balance between innovation and the inherently risk-averse nature of the clinical research industry. With extensive experience working for companies of various sizes, Adam has had the opportunity to observe and lead the implementation of innovation. In this episode, he shares his observations and discusses the tension between innovation and established processes, highlighting how legacy workflows can sometimes limit progress. He and Sylvain reflect on the challenge of introducing new technologies into environments where teams are incentivized to avoid risk, and where change can feel disruptive rather than enabling. Adam makes an important point about the importance of mindset and culture. He emphasizes that innovation is not just about technology itself, but about creating an environment where teams feel confident to challenge the status quo, rethink processes, and adopt new ways of working. Tune in to explore how the clinical industry can strike the right balance between stability and innovation, why…

People in this episode

Host: Sylvain Berthelot

Guest: Adam Walker

Topics covered

  • innovation
  • risk aversion
  • clinical research
  • data management
  • biometrics

Keywords

  • clinical trials
  • technology
  • mindset
  • culture
  • transformation

More episodes of Clinical Data Talks

Explore listener stats, chart rankings, contacts and more on the Clinical Data Talks podcast page.